First name: Heloise
  Last name: Delagreverie
  Function: MCU-PH
  Position: Virologie, hôpital Avicenne AP-HP
  Email: heloise.delagreverie

Research interest

My main research interests are HIV pathophysiology and reservoir persistence in HIV-1 and HIV-2 infections, antiretroviral therapy and resistance.



2015 : MD in clinical microbiology, Paris 5 University
2018 : PhD in virology, Paris 7 University

Academic positions

2015-2018 : Praticien Attaché in Virology, Hôpital Saint-Louis AP-HP
2018-2020 : AHU in Virology, CHU de Strasbourg
2020-2022 : AHU in Virology, Hôpital Avicenne AP-HP
2022-2023 : PHU in Virology, Hôpital Avicenne AP-HP
2023– : MCU-PH in Virology, Hôpital Avicenne AP-HP

Research training (post doctoral)

2007-2008 : Master IMVI Immunology, Pasteur Institute and University Paris Diderot ; INSERM U783, Necker Hospital
2015-2018 : PhD in Virology, University Paris Diderot ; INSERM U941, Saint-Louis Hospital

Exhaustive list of publications


Hassold N, Brichler S, Gater Y, Leclerc D, Gordien E, Bouchaud O, Carbonnelle E, Mechai F, Cordel H, Delagreverie H
Mixed outcomes following a third SARS-CoV-2 vaccine dose in previously unresponsive people with HIV.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2023, 158, 105347.


Hassold N, Brichler S, Ouedraogo E, Leclerc D, Carroue S, Gater Y, Alloui C, Carbonnelle E, Bouchaud O, Mechai F, Cordel H, Delagreverie H
Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
AIDS (London, England) 2022, 36, F1-F5.

Rahib D, Bercot B, Delagreverie H, Gabassi A, Delaugerre C, Salord H, Icard V, Le Thi TT, Leveau B, Khiri H, Digne J, Didelot MN, Pisoni A, Tuaillon E, Lydié N, Vandentorren S
Online self-sampling kits for human immunodeficiency virus and other sexually transmitted infections: Feasibility, positivity rates, and factors associated with infections in France.
International journal of STD & AIDS 2022, 33, 355-362.


Delagreverie HM, Grude M, Lambert-Niclot S, Nere ML, Jadand C, Leport C, Raffi F, Ghislain M, Goujard C, Meyer L, Calvez V, Katlama C, Flandre P, Barin F, Delaugerre C
Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1389-1394.


Wirden M, Larrouy L, Mahjoub N, Todesco E, Damond F, Delagreverie H, Akhavan S, Charpentier C, Chaix ML, Descamps D, Calvez V, Marcelin AG
Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 96, 49-53.